While Semaglutide works on a single hormone receptor and Tirzepatide works on 2, Retatrutide hits 3 different hormone receptors, which enhances the potency and effectiveness of the agent
Here is what FDA public regulatory sources confirm as of May 2026: The FDA removed tirzepatide from its drug shortage list in December 2024 and semaglutide in February 2025
Cooper highlights landmark studies (Minnesota Starvation Experiment, Dutch famine, the "Biggest Loser" follow-up) illustrating how diets slow metabolism and can even cause lasting damage
As a former prosecutor and former Deputy Attorney General of Missouri, Kelly brings nearly two decades of courtroom experience and a distinguished record in advocacy
In addition, a follow-up study by Beata et al
Treat every cross-trial contrast in this article as suggestive context rather than proof of superiority